Health insurance fund to cover several Hepatitis C drugs

A health worker collects a blood sample for hepatitis C test (Photo: VNA)

Hanoi (VNA) – Several new-generation
drugs for will be covered by the as
part of a recently-released circular by the .  

After consulting with experts and leading
hospitals, the health and insurance sector agreed to bring new drugs for
hepatitis C treatment into the list of medicine covered by health insurance
fund, said Prof. Nguyen Van Kinh, Director of the National Hospital of Tropical
Diseases.

Kinh said that the new medications help shorten
treatment duration because they are effective and have fewer side effects.

The inclusion of new drugs to treat hepatitis C
on the list covered by health insurance opens more opportunities for Vietnamese
patients to access advanced treatments, he said.

Nguyen Trong Khoa, Deputy Director of the Health
Ministry’s Preventive Medicine Department, said Vietnam ranks 4th in the world
in terms of mortality from liver cancer. The country has about one million
people infected with hepatitis C virus and 10 million infected with hepatitis
B, so the community’s need for treatment services is increasing day by day, he
said.

The practice is an important milestone to
achieve the goal to eliminate hepatitis by 2030 and reduce the burden of liver
diseases in Vietnam, said Khoa, adding that hepatitis C and hepatitis B are the
main causes of liver diseases in Vietnam.

Antiviral medicines can cure more than 95 percent
of people with hepatitis C, thereby reducing the risk of death from liver
cancer and cirrhosis, but access to diagnosis and treatment is low, according
to Khoa.

Khoa said the Health Ministry also worked with
foreign pharmaceutical companies to franchise drug production and boost
production in Vietnam at a cheaper price, creating favourable conditions for
patients to access treatments for liver diseases.

Hepatitis C is a liver disease caused by hepatitis
C virus, according to the World Health Organisation (WHO).

According to WHO, some 71 million people have
chronic hepatitis C infections globally whereas about 399,000 people die each
year from hepatitis C, mostly from cirrhosis and hepatocellular carcinoma.-VNA